Home › Compare › ASTTF vs MRK

ASTTF vs MRK: Dividend Comparison 2026

ASTTF yields 66666.67% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASTTF wins by $8.441837856534449e+24M in total portfolio value
10 years
ASTTF
ASTTF
● Live price
66666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.441837856534449e+24M
Annual income
$8,417,001,582,403,749,000,000,000,000,000.00
Full ASTTF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — ASTTF vs MRK

📍 ASTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASTTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASTTF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ASTTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASTTF
Annual income on $10K today (after 15% tax)
$5,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$7,154,451,345,043,187,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, ASTTF beats the other by $7,154,451,345,043,187,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASTTF + MRK for your $10,000?

ASTTF: 50%MRK: 50%
100% MRK50/50100% ASTTF
Portfolio after 10yr
$4.2209189282672247e+24M
Annual income
$4,208,500,791,201,874,400,000,000,000,000.00/yr
Blended yield
99.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ASTTF
No analyst data
Altman Z
-8.0
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASTTF buys
0
MRK buys
0
No recent congressional trades found for ASTTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASTTFMRK
Forward yield66666.67% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$8.441837856534449e+24M$30.7K ✓
Annual income after 10y$8,417,001,582,403,749,000,000,000,000,000.00 ✓$950.29
Total dividends collected$8.44020886744369e+24M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ASTTF vs MRK ($10,000, DRIP)

YearASTTF PortfolioASTTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$6,677,367$6,666,666.67$11,192$351.54+$6.67M → ASTTF
2$4,167,497,846$4,160,353,063.34$12,524$392.70+$4167.49M → ASTTF
3$2,431,161,901,635$2,426,702,678,939.67$14,015$438.65+$2431161.89M → ASTTF
4$1,325,636,209,022,888$1,323,034,865,788,139.00$15,682$489.96+$1325636209.01M → ASTTF
5$675,632,775,263,916,700$674,214,344,520,262,300.00$17,547$547.23+$675632775263.90M → ASTTF
6$321,867,481,182,444,260,000$321,144,554,112,911,900,000.00$19,632$611.16+$321867481182444.25M → ASTTF
7$143,326,993,661,751,470,000,000$142,982,595,456,886,240,000,000.00$21,963$682.53+$143326993661751472.00M → ASTTF
8$59,657,925,421,851,500,000,000,000$59,504,565,538,633,426,000,000,000.00$24,571$762.18+$59657925421851500544.00M → ASTTF
9$23,211,471,150,187,795,000,000,000,000$23,147,637,169,986,416,000,000,000,000.00$27,486$851.08+$2.3211471150187796e+22M → ASTTF
10$8,441,837,856,534,450,000,000,000,000,000$8,417,001,582,403,749,000,000,000,000,000.00$30,745$950.29+$8.441837856534449e+24M → ASTTF

ASTTF vs MRK: Complete Analysis 2026

ASTTF — Stock

Australis Oil & Gas Limited engages in the oil and gas exploration, development, and production activities in the United States. The company operates through Oil & Gas Production, Exploration, and Other segments. It holds interest in the Tuscaloosa Marine Shale covering an area of approximately 98,000 net acres located in Louisiana and Mississippi, the United States. Australis Oil & Gas Limited was incorporated in 2015 and is headquartered in Subiaco, Australia.

Full ASTTF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this ASTTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASTTF vs SCHDASTTF vs JEPIASTTF vs OASTTF vs KOASTTF vs MAINASTTF vs JNJASTTF vs ABBVASTTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.